




Searching News Database: MIV Therapeutics
HSMN NewsFeed - 20 May 2008
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
HSMN NewsFeed - 7 Jan 2008
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
HSMN NewsFeed - 22 Oct 2007
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
HSMN NewsFeed - 27 Oct 2006
MIV Therapeutics Announces Timeline for First Human Implantation of HAp NanoFilm Coated Stent
MIV Therapeutics Announces Timeline for First Human Implantation of HAp NanoFilm Coated Stent
HSMN NewsFeed - 14 Sep 2006
MIV Therapeutics Names Harvard Interventional Cardiologist Dr. Joseph Carrozza to Scientific Advisory Board
MIV Therapeutics Names Harvard Interventional Cardiologist Dr. Joseph Carrozza to Scientific Advisory Board
HSMN NewsFeed - 5 May 2006
MIV Therapeutics Establishes U.S. Corporate Headquarters with Opening of New Offices in Atlanta, GA
MIV Therapeutics Establishes U.S. Corporate Headquarters with Opening of New Offices in Atlanta, GA
Additional items found! 23

Members Archive contains
23 additional stories matching:
MIV Therapeutics
(Password required)
MIV Therapeutics
(Password required)